BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16964373)

  • 21. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer.
    Artandi SE; Attardi LD
    Biochem Biophys Res Commun; 2005 Jun; 331(3):881-90. PubMed ID: 15865944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomerase, senescence and ageing.
    Shawi M; Autexier C
    Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
    Attardi LD
    Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere length and radiosensitivity in human fibroblast clones immortalized by ectopic telomerase expression.
    Zongaro S; Verri A; Giulotto E; Mondello C
    Oncol Rep; 2008 Jun; 19(6):1605-9. PubMed ID: 18497972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomeres: hallmarks of radiosensitivity.
    Ayouaz A; Raynaud C; Heride C; Revaud D; Sabatier L
    Biochimie; 2008 Jan; 90(1):60-72. PubMed ID: 18006207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation.
    Uziel O; Reshef H; Ravid A; Fabian I; Halperin D; Ram R; Bakhanashvili M; Nordenberg J; Lahav M
    Br J Haematol; 2008 Jul; 142(1):82-93. PubMed ID: 18477050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
    Xiao CY; Zhou FX; Liu SQ; Xie CH; Dai J; Zhou YF
    Ai Zheng; 2005 Jun; 24(6):653-6. PubMed ID: 15946472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
    Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
    Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere dysfunction drives chromosomal instability in human mammary epithelial cells.
    Soler D; Genescà A; Arnedo G; Egozcue J; Tusell L
    Genes Chromosomes Cancer; 2005 Dec; 44(4):339-50. PubMed ID: 16052508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells.
    Page TJ; Mata JE; Bridge JA; Siebler JC; Neff JR; Iversen PL
    Exp Cell Res; 1999 Oct; 252(1):41-9. PubMed ID: 10502398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomeres and telomerase in normal and leukemic hematopoietic cells.
    Engelhardt M; Wäsch R; Guo Y
    Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible role for telomerase RNA and telomere length in global mitotic recombination.
    Bouffler SD; Finnon P; Blasco MA; Ainsbury E
    Cytogenet Genome Res; 2008; 122(3-4):292-6. PubMed ID: 19188698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against chromosome degradation at the telomeres.
    Grandin N; Charbonneau M
    Biochimie; 2008 Jan; 90(1):41-59. PubMed ID: 17764802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombination: a means to an end in human cells.
    Smith S
    Nat Genet; 2000 Dec; 26(4):388-9. PubMed ID: 11101826
    [No Abstract]   [Full Text] [Related]  

  • 39. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres.
    Akimcheva S; Zellinger B; Riha K
    Cytogenet Genome Res; 2008; 122(3-4):388-95. PubMed ID: 19188710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
    Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
    Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.